Resolution and quantification of arginine, monomethylarginine, asymmetric dimethylarginine, and symmetric dimethylarginine in plasma using HPLC with internal calibration

Biomedical Chromatography

Volumn 30, Issue 3, 2016, Pages 294-300

  Alkaitis, Matthew S ^a,b   Nardone, Glenn ^a   Chertow, Jessica H ^a   Ackerman, Hans C ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

ADMA; Arginine; L NMMA; Nitric Oxide Synthase; SDMA; Vascular Homeostasis

Indexed keywords

BIOMOLECULES; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MAMMALS; METABOLITES; NITRIC OXIDE; POSITIVE IONS;

ASYMMETRIC DIMETHYLARGININE; COEFFICIENT OF VARIATION VALUES; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN PLASMAS; L-ARGININE; L-NMMA; MICE PLASMA; NITRIC OXIDE SYNTHASES; SYMMETRIC DIMETHYLARGININE; VASCULAR HOMEOSTASIS;

ARGININE;

3 MERCAPTOPROPIONIC ACID; 6 N,N' DIMETHYLARGININE; ALDEHYDE; ARGININE; N(G) METHYLARGININE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE SYNTHASE;

ADULT; ARTICLE; CALIBRATION; CATION EXCHANGE; CONCENTRATION (PARAMETERS); HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; METABOLITE; PLASMA; SEPARATION TECHNIQUE; VALIDATION STUDY; ANIMAL; BLOOD; C57BL MOUSE; LIMIT OF DETECTION; MALE; MOUSE; PROCEDURES; REPRODUCIBILITY; STANDARDS; STATISTICAL MODEL;

ANIMALS; ARGININE; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; LIMIT OF DETECTION; LINEAR MODELS; MALE; MICE; MICE, INBRED C57BL; REPRODUCIBILITY OF RESULTS;

EID: 84956776828     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.3548     Document Type: Article

References (33)

1. Achan V, Broadhead M, Malaki M, Whitley G, Leiper J, MacAllister R and Vallance P. Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arteriosclerosis, Thrombosis, and Vascular Biology 2003; 23: 1455-1459. DOI:10.1161/01.ATV.0000081742.92006.59.
2. Armbruster DA and Pry T. Limit of blank, limit of detection and limit of quantitation. Clinical and Biochemical Reviews 2008; 29(suppl. 1): S49-52.
3. Bishop MJ, Crow B, Norton D, Paliakov E, George J and Bralley JA. Direct analysis of un-derivatized asymmetric dimethylarginine (ADMA) and l-arginine from plasma using mixed-mode ion-exchange liquid chromatography-tandem mass spectrometry. Journal of Chromatography B 2007; 859: 164-169. DOI:10.1016/j.jchromb.2007.09.024.
4. Blackwell S, O'Reilly DS and Talwar DK. HPLC analysis of asymmetric dimethylarginine (ADMA) and related arginine metabolites in human plasma using a novel non-endogenous internal standard. Clinica Chimica Acta 2009; 401: 14-9. DOI:10.1016/j.cca.2008.10.032.
5. Bode-Böger SM, Scalera F, Kielstein JT, Martens-Lobenhoffer J, Breithardt G, Fobker M and Reinecke H. Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease. Journal of the American Society for Nephrology 2006; 17: 1128-1134. DOI:10.1681/ASN.2005101119.
6. Böger RH, Bode-Böger SM, Szuba A, Tsao PS, Chan JR, Tangphao O, Blaschke TF and Cooke JP. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction its role in hypercholesterolemia. Circulation 1998; 98: 1842-1847. DOI:10.1161/01.CIR.98.18.1842.
7. Cardounel AJ, Cui H, Samouilov A, Johnson W, Kearns P, Tsai AL, Berka V and Zweier JL. Evidence for the pathophysiological role of endogenous methylarginines in regulation of endothelial NO production and vascular function. Journal of Biological Chemistry 2007; 282: 879-887. DOI:10.1074/jbc.M603606200.
8. Closs EI, Basha FZ, Habermeier A and Forstermann U. Interference of l-arginine analogues with l-arginine transport mediated by the y+carrier hCAT-2B. Nitric Oxide 1997; 1: 65-73. DOI:10.1006/niox.1996.0106.
9. El-Khoury J, Bunch D, Reineks E, Jackson R, Steinle R and Wang S. A simple and fast liquid chromatography-tandem mass spectrometry method for measurement of underivatized l-arginine, symmetric dimethylarginine, and asymmetric dimethylarginine and establishment of the reference ranges. Analytical and Bioanalytical Chemistry 2012; 402: 771-779. DOI:10.1007/s00216-011-5462-9.
10. Gervasoni J, Bonelli F, Zuppi C, Zappacosta B, Mordente A, Calvani R and Persichilli S. Determination of asymmetric dimethyl arginine in human serum by liquid chromatography-tandem mass spectrometry: clinical application in hypertensive subjects. Clinical Chemistry and Laboratory Medicine 2011; 49: 2109-2115. DOI:10.1515/CCLM.2011.691.
11. TM fluorescent derivatives. Journal of Chromatography B 2004; 805: 325-329. DOI: 10.1016/j.jchromb.2004.03.020.
12. Jones CE, Darcy CJ, Woodberry T, Anstey NM and McNeil YR. HPLC analysis of asymmetric dimethylarginine, symmetric dimethylarginine, homoarginine and arginine in small plasma volumes using a Gemini-NX column at high pH. Journal of Chromatography B: Analytical Technology in Biomedicine and Life Sciences 2010; 878: 8-12. DOI:10.1016/j.jchromb.2009.10.035.
13. Kakimoto Y and Akazawa S. Isolation and Identification of Ng, Ng- and Ng, N′g-dimethylarginine, Nε-mono-, di-, and trimethyllysine, and glucosylgalactosyl- and galactosyl-δ-hydroxylysine from human urine. Journal of Biological Chemistry 1970; 245: 5751-5758.
14. Kato GJ, Wang Z, Machado RF, Blackwelder WC, Taylor JG VIth and Hazen SL. Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and death. British Journal of Haematology 2009; 145: 506-513. DOI: 10.1111/j.1365-2141.2009.07658.x.
15. Kielstein JT and Cooke JP. Should we measure asymmetric dimethylarginine in patients with coronary artery disease? Clinical Chemistry 2007; 53: 161-163. DOI:10.1373/clinchem.2006.078881.
16. Kielstein JT, Impraim B, Simmel S, Bode-Böger SM, Tsikas D, Frölich JC, Hoeper MM, Haller H and Fliser D. Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans. Circulation 2004; 109: 172-177. DOI:10.1161/01.CIR.0000105764.22626.B1.
17. Kielstein JT, Salpeter SR, Bode-Boeger SM, Cooke JP and Fliser D. Symmetric dimethylarginine (SDMA) as endogenous marker of renal function - a meta-analysis. Nephrology, Dialysis and Transplantation 2006; 21: 2446-2451. DOI:10.1093/ndt/gfl292.
18. Kirchherr H and Kühn-Velten WN. HPLC-tandem mass spectrometric method for rapid quantification of dimethylarginines in human plasma. Clinical Chemistry 2005; 51: 249-252. DOI:10.1373/clinchem.2004.042663.
19. Lee HW, Kim S and Paik WK. S-Adenosylmethionine:protein-arginine methyltransferase. Purification and mechanism of the enzyme. Biochemistry (Moscow) 1977; 16: 78-85. DOI:10.1021/bi00620a013.
20. Marra M, Bonfigli AR, Testa R, Testa I, Gambini A and Coppa G. High-performance liquid chromatographic assay of asymmetric dimethylarginine, symmetric dimethylarginine, and arginine in human plasma by derivatization with naphthalene-2, 3-dicarboxaldehyde. Analytical Biochemistry 2003; 318: 13-17. DOI:10.1016/S0003-2697(03)00157-X.
21. Martens-Lobenhoffer J and Bode-Böger SM. Simultaneous detection of arginine, asymmetric dimethylarginine, symmetric dimethylarginine and citrulline in human plasma and urine applying liquid chromatography-mass spectrometry with very straightforward sample preparation. Journal of Chromatography B 2003; 798: 231-239. DOI:10.1016/j.jchromb.2003.09.050.
22. Molnar-Perl I. Derivatization and chromatographic behavior of the o-phthaldialdehyde amino acid derivatives obtained with various SH-group-containing additives. Journal of chromatography A 2001; 913: 283-302.
23. Perticone F, Sciacqua A, Maio R, Perticone M, Maas R, Boger RH, Tripepi G, Sesti G and Zoccali C. Asymmetric dimethylarginine, l-arginine, and endothelial dysfunction in essential hypertension. Journal of the American College of Cardiology 2005; 46: 518-523. DOI:10.1016/j.jacc.2005.04.040.
24. Schnabel R, Blankenberg S, Lubos E, Lackner KJ, Rupprecht HJ, Espinola-Klein C, Jachmann N, Post F, Peetz D, Bickel C, Cambien F, Tiret L and Münzel T. Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease results from the AtheroGene Study. Circulation Research 2005; 97: e53-e59. DOI:10.1161/01.RES.0000181286.44222.61.
25. Schulze F, Wesemann R, Schwedhelm E, Sydow K, Albsmeier J, Cooke JP and Böger RH. Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay. Clinical Chemistry and Laboratory Medicine CCLM FESCC 2004; 42: 1377-1383. DOI:10.1515/CCLM.2004.257.
26. Schwedhelm E, Maas R, Tan-Andresen J, Schulze F, Riederer U and Böger RH. High-throughput liquid chromatographic-tandem mass spectrometric determination of arginine and dimethylated arginine derivatives in human and mouse plasma. Journal of Chromatography B 2007; 851: 211-219. DOI:10.1016/j.jchromb.2006.11.052.
27. Servillo L, Giovane A, D'Onofrio N, Casale R, Cautela D, Castaldo D and Balestrieri ML. Determination of homoarginine, arginine, NMMA, ADMA, and SDMA in biological samples by HPLC-ESI-mass spectrometry. International Journal of Molecular Science 2013; 14: 20131-20138. DOI:10.3390/ijms141020131.
28. Suzuki K, Katayama M, Takamatsu K, Kaneko S, Ishikawa H, Tsukimura T and Togawa T. The stableo-phthalaldehyde-ferrocene/6-ferrocenyl-1-hexanethiol pre-column derivatization high-performance liquid chromatography of dimethylarginine by novel dual fluorescence and electrochemical detector. Biomedical Chromatography 2013; 27: 535-538. DOI: 10.1002/bmc.2823.
29. Teerlink T, Nijveldt RJ, de Jong S and van Leeuwen PA. Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Analytical Biochemistry 2002; 303: 131-7.
30. Vallance P, Leone A, Calver A, Collier J and Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339: 572-575.
31. Worthmann H, Chen S, Martens-Lobenhoffer J, Li N, Deb M, Tryc AB, Goldbecker A, Dong Q, Kielstein JT, Bode-Böger SM and Weissenborn K. High plasma dimethylarginine levels are associated with adverse clinical outcome after stroke. Journal of Atherosclerosis and Thrombosis 2011; 18: 753-761.
32. Zhang WZ and Kaye DM. Simultaneous determination of arginine and seven metabolites in plasma by reversed-phase liquid chromatography with a time-controlled ortho-phthaldialdehyde precolumn derivatization. Analytical Biochemistry 2004; 326: 87-92. DOI:10.1016/j.ab.2003.11.006.
33. Zoccali C, Bode-Böger S, Mallamaci F, Benedetto F, Tripepi G, Malatino L, Cataliotti A, Bellanuova I, Fermo I, Frölich J and Böger R. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 2001; 358: 2113-2117.